Company news
Mabpharm Limited news in 2026
Mabpharm Limited's news releases, calls and decks from 2026, newest first.
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
November 3, 2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
October 6, 2026
2026 Interim Report
September 21, 2026
Third Amended and Restated memorandum and articles of association
June 26, 2026
Voluntary announcement approval from the national medical products administration on the new drug application (nda) of our pipeline product, CMAB807X (denosumab injection)
June 24, 2026